I used to own and believe in AEGR. I have been sitting out for quite awhile, wanting to see how the earnings progressed. The r3evenue is totally underwhelming, and unfortunately AEGR isn't growing fast enough to stave off Amgen and Regeneron/Sanofi with their new drugs coming out. Amgen's in particular has been shown to address some of the medical needs of the AEGR patient base. I think the company was a flash in the pan. Just my two cents, and trust me, I'm not short. I'm an observer only right now.